Department of Pharmacology and Chemical Biology, Hillman Cancer Center, University of Pittsburgh School of Medicine (UPMC), Pittsburgh, PA, USA.
Department of Pharmacology and Chemical Biology, Hillman Cancer Center, University of Pittsburgh School of Medicine (UPMC), Pittsburgh, PA, USA.
Trends Cancer. 2020 Mar;6(3):247-260. doi: 10.1016/j.trecan.2019.12.009. Epub 2020 Jan 23.
Alternative lengthening of telomeres (ALT) is a mechanism of telomere maintenance that is observed in many of the most recalcitrant cancer subtypes. Telomeres in ALT cancer cells exhibit a distinctive nucleoprotein architecture shaped by the mismanagement of chromatin that fosters cycles of DNA damage and replicative stress that activate homology-directed repair (HDR). Mutations in specific chromatin-remodeling factors appear to be key determinants of the emergence and survival of ALT cancer cells. However, these may represent vulnerabilities for the targeted elimination of ALT cancer cells that infiltrate tissues and organs to become devastating tumors. In this review we examine recent findings that provide new insights into the factors and mechanisms that mediate telomere length maintenance and survival of ALT cancer cells.
端粒的非经典延长(ALT)是端粒维持的一种机制,在许多最顽固的癌症亚型中都有观察到。ALT 癌细胞中的端粒表现出独特的核蛋白结构,这种结构是由染色质的错误管理形成的,促进了 DNA 损伤和复制应激的循环,从而激活同源重组修复(HDR)。特定染色质重塑因子的突变似乎是 ALT 癌细胞出现和存活的关键决定因素。然而,这些可能代表着靶向消除浸润组织和器官并成为致命肿瘤的 ALT 癌细胞的脆弱性。在这篇综述中,我们研究了最近的发现,这些发现为介导端粒长度维持和 ALT 癌细胞存活的因素和机制提供了新的见解。